Ustecinumab 130 mg/26 ml sol inj fr 26 ml IV e Ustecinumab 90 mg/1 ml sol inj caneta 1 ml SC
TED · 496760-2026Award notice · social & specific servicesawardedNo deadline given
Value
Estimated—
Awarded€953,414 · 953,413.6 EUR
WinnerJanssen Cilag Farmacêutica, Lda
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de São José, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Johnson & Johnson, Lda. | 2 | €1,265,691 | 2026-07-06 |
| Roche Sistemas de Diagnósticos, Lda | 1 | €2,501,888 | 2026-07-14 |
| Excelencia Robótica, Unipessoal Lda. | 1 | €1,479,377 | 2026-05-18 |
| Astellas Farma, Lda | 1 | €1,328,458 | 2026-07-17 |
| Acuña y Fombona Portugal, S.A. | 1 | €580,304 | 2026-07-06 |
Full buyer profile: what Unidade Local de Saúde de São José, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
41005326 - Ustecinumab 130 mg/26 ml sol inj fr 26 ml IV e Ustecinumab 90 mg/1 ml sol inj caneta 1 ml SC